Universidad Complutense de Madrid-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2024

  1. NKG2C/KLRC2 tumor cell expression enhances immunotherapeutic efficacy against glioblastoma

    Journal for immunotherapy of cancer, Vol. 12, Núm. 8